登录

Carespan Health以100万美元剥离对Carespan Asia的兴趣

Carespan Health divests interest in CareSpan Asia for $1 million

seekingalpha 2024-03-04 20:19 翻译由动脉网AI生成,点击反馈

可切换为仅中文


CareSpan Health (TSXV:CSPN:CA) Monday announced that on February 29, it closed a transaction for aggregate gross proceeds of approximately $1 million, involving the sale of the company's 15% minority equity interest in CareSpan Asia, a Philippines based company, and exchange of certain software rights.

CareSpan Health(TSXV:CSPN:CA)周一宣布,2月29日,它完成了一笔总收入约100万美元的交易,涉及出售该公司在菲律宾公司CareSpan Asia 15%的少数股权,并交换某些软件权利。

The net proceeds from the transaction will be used to focus and further build out the company's offerings in the U.S. market and for general business and working capital purposes. CareSpan Asia purchased the remaining equity interest of their company from CareSpan and obtained the rights to exclusively use CareSpan's platform technology in the Asia-Pacific region and for non-exclusive use in South America.

交易产生的净收益将用于集中和进一步扩大公司在美国市场的发行,以及用于一般业务和营运资本目的。CareSpan Asia从CareSpan购买了其公司的剩余股权,并获得了在亚太地区独家使用CareSpan平台技术以及在南美非独家使用的权利。

Source: Press Release More on CareSpan Health Financial information for CareSpan Health .

来源:有关CareSpan Health的更多新闻稿CareSpan Health财务信息。

推荐阅读

与NeoRAS野生型转移性癌症相关的临床特征——SCRUM-Japan GOZILA亚研究

Nature 2024-07-13 19:13

Infinx Healthcare在班加罗尔建立了一个新的最先进的研发中心,以扩大其在印度的业务,推动人工智能驱动的医疗保健RCM创新

Medgate Today 2024-07-13 18:51

再次推动生物化工、非粮碳源、生物酶催化产业

seekingalpha

412篇

最近内容 查看更多

2024年迄今为止表现最好的10只生物技术股

2024-03-07

Creative Medical股价上涨18%,脆性1型糖尿病候选疗法获授予孤儿药称号

2024-03-06

Cyclacel Pharmaceuticals获得290万美元的研发税收抵免

2024-03-06

产业链接查看更多